Medicus Pharma Ltd. (CVE:MDC – Free Report) – Brookline Capital Management dropped their FY2025 earnings per share estimates for Medicus Pharma in a research report issued to clients and investors on Tuesday, November 18th. Brookline Capital Management analyst K. Raja now anticipates that the company will post earnings of ($2.84) per share for the year, down from their previous estimate of ($1.96). Brookline Capital Management also issued estimates for Medicus Pharma’s Q4 2025 earnings at ($0.45) EPS, FY2026 earnings at ($1.75) EPS, FY2027 earnings at ($1.34) EPS and FY2028 earnings at ($0.11) EPS.
Medicus Pharma Price Performance
Further Reading
- Five stocks we like better than Medicus Pharma
- What is a Bond Market Holiday? How to Invest and Trade
- onsemi Places a $6 Billion Bet on Its Own Stock
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- End the Year Strong With These 3 Comeback Champions
Receive News & Ratings for Medicus Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicus Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
